title: [Perioperative management of patients with cardiomyopathies: preface and comments].
abstract: Cardiomyopathies are a heterogeneous group of diseases of the myocardium. Cardiomyopathies are characterized by myocardial dysfunction resulting in heart failure due to systolic dysfunction and/or diastolic dysfunction. Prognosis of the patients with cardiomyopathies is usually poor due to progressive heart failure. Sudden death due to serious arrhythmia is not uncommon. Because of the heterogeneity of cardiomyopathies, the perioperative management of the patients with cardiomyopathies varies according to the pathological physiology. Management of low cardiac output is important as well as arrhythmias. Because of arrhythmias such as atrial fibrillation and poor ventricular function, anticoagulation is also important. Through evaluation and management of implantable pacemakers and implantable cardioverter defibrillator are essential.
authors.affiliation: Department of Anesthesiology and Pain Medicine, University of Juntendo Medical School, Tokyo 113-8421.
authors.forename: Eiichi
authors.initials: E
authors.lastname: Inada
mesh_terms: D000925:Anticoagulants / Q000008:administration & dosage; D001145:Arrhythmias, Cardiac / Q000517:prevention & control / Q000628:therapy; D002303:Cardiac Output, Low / Q000517:prevention & control / Q000628:therapy; D009202:Cardiomyopathies / Q000145:classification / Q000209:etiology / Q000601:surgery*; D016757:Death, Sudden, Cardiac / Q000209:etiology / Q000517:prevention & control; D017147:Defibrillators, Implantable; D018450:Disease Progression; D006333:Heart Failure / Q000209:etiology / Q000517:prevention & control; D006801:Humans; D010138:Pacemaker, Artificial; D019990:Perioperative Care; D013514:Surgical Procedures, Operative
chemical_list: D000925:Anticoagulants